By
AmyT on
January 26, 2010
When the JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.
Usage Issues
Q) How much more advanced will this be than the Medtronic Paradigm Veo system launched in Europe, which stops insulin delivery for…
Read more »
By
AmyT on
November 13, 2009
Today, just a sampling of some of the interesting stuff presented at last week’s Diabetes Technology Society meeting, that will be out on the market in … um… some years from now (?):
IN-105 Oral Insulin for Type 2 diabetes – Biocon Limited, apparently India’s premier biotechnology company, has been developing oral insulin tablets for some years now. Positive research results were announced last year. And they’re not just for basal use, either. Studies confirmed…
Read more »
By
AmyT on
November 12, 2009
The Diabetes Technology Society held its annual meeting last Thursday through Saturday, which always takes place just about a mile and a half from my house. But guess what? This was the very first year that I found myself on the inside of this exclusive event, participating in a panel (the very last panel of the 3-day event) on “technologies to drive patient adherence.”
The term “adherence” made me bristle, too, because it sounds like…
Read more »
By
AmyT on
August 3, 2009
John Smith is considered one of the country’s premiere experts on non-invasive glucose monitoring technology. He previously served as Vice President and Chief Scientific Officer of Johnson & Johnson’s LifeScan, a world market leader in blood glucose monitoring systems. John now consults for companies pursuing noninvasive glucose methods, and for investors who fund them. He is the author of The Pursuit of Noninvasive Glucose: “Hunting the Deceitful Turkey,” which is available for download here. He’s…
Read more »
By
AmyT on
November 20, 2008
So my “mole” who attended the Diabetes Technology Society meeting in Maryland last week got back to me, and the news was kind of disappointing. On the whole, it doesn’t sound like there’s anything particularly new under the sun for us PWDs at the moment; it’s all about more baby steps in research and development.
But Aaron Kowalski, Research Director of the JDRF, might disagree with me there. He delivered a keynote address entitled “Accelerating…
Read more »
